Rocket Pharmaceuticals is engaged in the development of gene therapy cures for rare diseases, with a focus on addressing genetic conditions through innovative science and clinical platforms.

Rocket Pharmaceuticals

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.

COM:ROCKETPHARMA

Rocket Pharmaceuticals

Last Close

12.79

22/11 21:00

Market Cap

1.29B

Beta: -

Volume Today

1.19M

Avg: -

Analysis Not Available